COVID-19 Pharmaceutical Consumables Expansion and Acceleration: Single-Use Bags and Assemblies

This combined synopsis and solicitation from the Department of Health and Human Services seeks proposals to expand domestic manufacturing capacity for single-use consumable products supporting COVID-19 vaccines, including customizable single-use tubing assemblies, pumps, mixing systems, and sterile packaged components. Offerors must propose a schedule with measurable milestones and payments to increase capacity of these products by November 2022, with expanded capacity then sustained for ten years. Proposals will be evaluated on technical capability, price, and past performance, with evaluation completed by October 29, 2021.

The solicitation is set aside for total small business and seeks a firm fixed price contract not to exceed $15 million. The place of performance is the United States. Offerors must provide their lowest commercial pricing and one to four relevant past performance examples supplying COVID-19 vaccine manufacturers. Priority ordering will be provided at the expanded production levels for ten years to contractors who can increase domestic capacity of these products, classified under NAICS 325414 and PSC 6515, by November 2022.